News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,968 Results
Type
Article (38017)
Company Profile (14)
Press Release (223937)
Multimedia
Podcasts (11)
Webinars (10)
Section
Business (71063)
Career Advice (958)
Deals (8028)
Drug Delivery (37)
Drug Development (36481)
Employer Resources (70)
FDA (6765)
Job Trends (5543)
News (123963)
Policy (12706)
Tag
Academia (2521)
Academic (1)
Accelerated approval (3)
Adcomms (14)
Allergies (34)
Alliances (15784)
ALS (44)
Alzheimer's disease (750)
Antibody-drug conjugate (ADC) (44)
Approvals (6787)
Artificial intelligence (109)
Autoimmune disease (6)
Automation (5)
Bankruptcy (152)
Best Places to Work (4915)
BIOSECURE Act (6)
Biosimilars (33)
Biotechnology (16)
Bladder cancer (44)
Brain cancer (16)
Breast cancer (163)
Cancer (1178)
Cardiovascular disease (89)
Career advice (831)
Career pathing (15)
CAR-T (78)
Cell therapy (204)
Cervical cancer (12)
Clinical research (29245)
Collaboration (299)
Company closure (1)
Compensation (98)
Complete response letters (5)
COVID-19 (1773)
CRISPR (16)
C-suite (173)
Cystic fibrosis (28)
Data (1218)
Decentralized trials (1)
Denatured (4)
Depression (21)
Diabetes (113)
Diagnostics (2624)
Digital health (5)
Diversity (5)
Diversity, equity & inclusion (21)
Drug discovery (45)
Drug pricing (42)
Drug shortages (11)
Duchenne muscular dystrophy (40)
Earnings (17628)
Editorial (18)
Employer branding (4)
Employer resources (61)
Events (27534)
Executive appointments (497)
FDA (7388)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (290)
Gene editing (46)
Generative AI (8)
Gene therapy (140)
GLP-1 (245)
Government (2245)
Grass and pollen (2)
Guidances (61)
Healthcare (7790)
Huntington's disease (6)
IgA nephropathy (12)
Immunology and inflammation (38)
Indications (13)
Infectious disease (1856)
Inflammatory bowel disease (65)
Inflation Reduction Act (4)
Influenza (39)
Intellectual property (36)
Interviews (160)
IPO (4061)
IRA (23)
Job creations (822)
Job search strategy (707)
Kidney cancer (8)
Labor market (14)
Layoffs (101)
Leadership (5)
Legal (3820)
Liver cancer (41)
Lung cancer (180)
Lymphoma (98)
Machine learning (5)
Management (26)
Manufacturing (85)
MASH (36)
Medical device (5282)
Medtech (5283)
Mergers & acquisitions (4090)
Metabolic disorders (245)
Multiple sclerosis (36)
NASH (10)
Neurodegenerative disease (50)
Neuropsychiatric disorders (6)
Neuroscience (984)
NextGen: Class of 2025 (2651)
Non-profit (2227)
Now hiring (6)
Obesity (101)
Opinion (108)
Ovarian cancer (48)
Pain (30)
Pancreatic cancer (42)
Parkinson's disease (53)
Partnered (6)
Patents (86)
Patient recruitment (54)
Peanut (19)
People (34567)
Pharmaceutical (1)
Pharmacy benefit managers (4)
Phase I (8619)
Phase II (12816)
Phase III (10090)
Pipeline (549)
Policy (67)
Postmarket research (1447)
Preclinical (3875)
Press Release (36)
Prostate cancer (57)
Psychedelics (12)
Radiopharmaceuticals (120)
Rare diseases (167)
Real estate (1696)
Recruiting (28)
Regulatory (7682)
Reports (14)
Research institute (1593)
Resumes & cover letters (125)
Rett syndrome (3)
RNA editing (2)
RSV (15)
Schizophrenia (27)
Series A (41)
Series B (29)
Sickle cell disease (21)
Special edition (4)
Spinal muscular atrophy (53)
Sponsored (17)
Startups (1356)
Stomach cancer (5)
Supply chain (10)
Tariffs (12)
The Weekly (7)
Vaccines (433)
Venture capitalists (10)
Weight loss (74)
Women's health (12)
Worklife (5)
Date
Last 7 days (329)
Last 30 days (1137)
Last 365 days (12538)
2025 (4439)
2024 (13433)
2023 (15722)
2022 (20961)
2021 (22809)
2020 (21758)
2019 (18631)
2018 (13811)
2017 (12984)
2016 (12751)
2015 (14720)
2014 (10881)
2013 (9933)
2012 (10011)
2011 (10120)
2010 (8993)
Location
Africa (442)
Alabama (14)
Alaska (3)
Arizona (70)
Arkansas (6)
Asia (15985)
Australia (3572)
California (2429)
Canada (645)
China (195)
Colorado (101)
Connecticut (130)
Delaware (61)
Europe (39778)
Florida (318)
Georgia (81)
Idaho (25)
Illinois (216)
India (7)
Indiana (133)
Iowa (5)
Japan (79)
Kansas (24)
Kentucky (7)
Louisiana (6)
Maine (15)
Maryland (309)
Massachusetts (1580)
Michigan (62)
Minnesota (143)
Mississippi (1)
Missouri (32)
Montana (9)
Nebraska (10)
Nevada (21)
New Hampshire (26)
New Jersey (768)
New Mexico (14)
New York (776)
North Carolina (438)
North Dakota (3)
Northern California (1174)
Ohio (92)
Oklahoma (6)
Oregon (11)
Pennsylvania (542)
Puerto Rico (1)
Rhode Island (13)
South America (486)
South Carolina (7)
Southern California (859)
Tennessee (35)
Texas (320)
United States (9007)
Utah (62)
Virginia (48)
Washington D.C. (23)
Washington State (281)
West Virginia (1)
Wisconsin (14)
261,968 Results for "case western reserve university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University
Mosaic ImmunoEngineering, Inc. announced the signing of a license agreement with Case Western Reserve University for patented technology discovered at Case Western Reserve University and Dartmouth College.
May 5, 2022
·
6 min read
PharmaTher Enters into Exclusive Option Agreement with Case Western Reserve University to Develop and Commercialize Ketamine for Rett Syndrome
PharmaTher Holdings Ltd. is pleased to announce that the Company has entered into an evaluation and exclusive option agreement with Case Western Reserve University in the development and commercialization for the intellectual property of ketamine in the treatment Rett Syndrome, a rare genetic neurological disorder.
November 1, 2022
·
6 min read
Press Releases
Paige and NHS Wales Launch PanCancer Pilot to Triage Cases with AI at Betsi Cadwaladr University Health Board
April 24, 2025
·
3 min read
Business
SCYNEXIS Announces $3 Million National Institutes of Health Grant Has Been Awarded to Case Western Reserve University Researchers to Study Second Generation Fungerp (SCY-247) to Fight Drug-Resistant Fungi
SCYNEXIS, Inc. today announced that researchers from Case Western Reserve University in Cleveland have been awarded a competitive research grant of more than $3 million by the National Institutes of Health (NIH), to investigate a second generation fungerp (SCY-247).
November 30, 2022
·
5 min read
Press Releases
Catheter Precision to Attend and Participate in the Western Atrial Fibrillation Symposium
February 27, 2025
·
2 min read
NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University
NervGen Pharma Corp., (TSX-V: NGEN) (OTCQX: NGENF), is pleased to announce the University of Cincinnati and Case Western Reserve University (CWRU) have published a pioneering preclinical study in the peer-reviewed scientific journal Cell Reports demonstrating that NervGen’s proprietary drug, NVG-291-R.
July 28, 2022
·
11 min read
Business
Forge Biologics and Case Western Reserve University Announce Gene Therapy Workforce Development Partnership
Forge Biologics and Case Western Reserve University Announce Gene Therapy Workforce Development Partnership
July 6, 2021
·
4 min read
BioMidwest
Evergreen Nephrology and Western Kentucky Kidney Specialists Announce Partnership
Evergreen Nephrology is pleased to announce a new partnership with Western Kentucky Kidney Specialists.
May 29, 2024
·
2 min read
Press Releases
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
April 30, 2025
·
3 min read
Opinion
Regulatory and Economic Turmoil Is More Familiar in Other Countries
Disruptive conditions are typical in non-Western markets. The U.S. industry, thrown into a period of significant change as the Trump administration overhauls HHS and considers implementing tariffs, could learn a thing or two by looking overseas.
April 21, 2025
·
5 min read
·
Cem Zorlular
1 of 26,197
Next
